Bihua Chen
Director/Board Member chez BIOMEA FUSION, INC.
Fortune : - $ au 31/03/2024
Profil
Bihua Chen is the founder and the Chief Executive Officer & Portfolio Manager of Cormorant Asset Management LP since 2013.
Ms. Chen is also the founder of Cormorant Asset Management LLC.
Ms. Chen's current job positions include Chairman & Chief Executive Officer of Helix Acquisition Corp.
II, Director of Atia Vision, Inc., Independent Director of Biomea Fusion, Inc., Director of Blossomhill Therapeutics, Inc., Director of Chroma Medicine, Inc., Director of Orionis Biosciences BV, Managing Member of C4 Therapeutics, Inc., Managing Member of CRMA SPV LP, Managing Member of Cormorant Private Healthcare Fund I LP, Managing Member of Cormorant Private Healthcare Fund II LP, and Manager of Helix Holdings LLC.
Ms. Chen's former job positions include Chairman & Chief Executive Officer of Helix Acquisition Corp.
(2020-2022), Independent Director of Apellis Pharmaceuticals, Inc., Director of Atea Pharmaceuticals, Inc., Director of Turning Point Therapeutics, Inc., Managing Director of North Tide Capital LLC, Independent Director of Kezar Life Sciences, Inc., Independent Director of Erasca, Inc., Senior Analyst of RiverSource Investments LLC, Principal of BB Biotech AG, Principal of American Express Asset Management International (UK), Equity Analyst of Putnam U.S.
Holdings I LLC (1998-2001), Portfolio Manager of Millennium Management LLC (2008), Portfolio Manager of Bellevue Research, Inc. (2000-2001), Portfolio Manager of American Express Asset Management Group Inc. (2001-2002), Principal of Asterion LLC, and Venture Partner of Impresa Management LLC.
Ms. Chen's education includes an undergraduate degree from Fudan University in 1990, a graduate degree from Weill Cornell Medical College in 1994, and an MBA from The Wharton School of the University of Pennsylvania in 1998.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
BIOMEA FUSION INC
-.--% | 14/06/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
ERASCA, INC.
-.--% | 15/04/2023 | 0 ( -.--% ) | - $ | 31/03/2024 |
Postes actifs de Bihua Chen
| Sociétés | Poste | Début |
|---|---|---|
| C4 THERAPEUTICS, INC. | Corporate Officer/Principal | - |
| BIOMEA FUSION, INC. | Director/Board Member | 01/12/2020 |
Orionis Biosciences BV
 Orionis Biosciences BV Pharmaceuticals: MajorHealth Technology Part of Orionis Biosciences, Inc., Orionis Biosciences BV operates as a drug discovery and Belgian development biotechnology company. The private company is based in Ghent, Belgium. The company was founded in 2015. Nikolai Kley has been the CEO of the company since 2015. | Director/Board Member | 29/06/2021 |
Chroma Medicine, Inc.
 Chroma Medicine, Inc. Pharmaceuticals: MajorHealth Technology Chroma Medicine, Inc. is a biotechnology company that pioneers a new class of genomic medicines using epigenetics to deliver precise, programmable single-dose therapeutics while preserving genomic integrity. The company is based in Cambridge, MA and has subsidiaries in Italy. The company's modular platform enables the development of medicines that can address a wide range of complex diseases, whether they require silencing, activation, or targeting multiple genes at once. Chroma Medicine was founded by the world's foremost experts in genomic research and is led by a veteran team of industry leaders and scientists with deep experience in genomic medicine, drug discovery, and development. Catherine Stehman-Breen has been the CEO of the company since 2020. | Director/Board Member | - |
| Helix Holdings LLC | Corporate Officer/Principal | - |
| CRMA SPV LP | Corporate Officer/Principal | - |
| Cormorant Private Healthcare Fund II LP | Corporate Officer/Principal | - |
| Cormorant Private Healthcare Fund I LP | Corporate Officer/Principal | - |
Atia Vision, Inc.
 Atia Vision, Inc. Electronic Equipment/InstrumentsElectronic Technology Atia Vision, Inc. provides medical device services. The company was founded in 2012 and is headquartered in Campbell, CA. | Director/Board Member | - |
| ░░░░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
| ░░░░░░░░░ ░░░░░ ░░░░░░░░░░ ░░░░░░░░░░░ ░░░░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Anciens postes connus de Bihua Chen
| Sociétés | Poste | Fin |
|---|---|---|
| ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░ ░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░ ░░░░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Bihua Chen
| Fudan University | Undergraduate Degree |
| Weill Cornell Medical College | Graduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 7 |
|---|---|
| BB BIOTECH AG | Finance |
| APELLIS PHARMACEUTICALS, INC. | Health Technology |
| ATEA PHARMACEUTICALS, INC. | Health Technology |
| KEZAR LIFE SCIENCES, INC. | Health Technology |
| C4 THERAPEUTICS, INC. | Health Technology |
| ERASCA, INC. | Health Technology |
| BIOMEA FUSION, INC. | Health Technology |
| Entreprise privées | 21 |
|---|---|
RiverSource Investments LLC
 RiverSource Investments LLC Investment ManagersFinance RiverSource Investments LLC, formerly American Express Financial Corp., is a registered investment advisor and mutual fund manager headquartered in Minneapolis, Minnesota with offices in New York City, Maryland, Massachusetts and California. The firm is a wholly-owned subsidiary of Ameriprise Financial Services, Inc. (NYSE: AMP). RiverSource Investments provides investment management services to the RiverSource Investments family of funds (formerly the American Express Funds). The firm also provides investment management services for institutional clients, alternative investments, insurance assets and a managed account program. | Finance |
American Express Asset Management International (UK)
 American Express Asset Management International (UK) Financial ConglomeratesFinance American Express Asset Management International (UK) is a global payments, network and travel firm which is headquartered in London, UK. | Finance |
Putnam U.S. Holdings I LLC
 Putnam U.S. Holdings I LLC Investment ManagersFinance Putnam Investments LLC operates as an investment advisory company. The company was founded on May 14, 2009 and is headquartered in Boston, MA. | Finance |
Turning Point Therapeutics, Inc.
 Turning Point Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Turning Point Therapeutics, Inc. is a clinical-stage oncology biopharmaceutical company, which engages in designing and developing next-generation therapies that target genetic drivers of cancer to improve the lives of patients. Its product pipeline include Repotrectinib, TPX-0022, TPX-0046, and TPS-O131, a next-gen ALK inhibitor. The company was founded by Jingrong Jean Cui and Y. Peter Li in October 2013 and is headquartered in San Diego, CA. | Health Technology |
Millennium Management LLC
 Millennium Management LLC Investment ManagersFinance Millennium Management LLC is a SEC-investment advisor and hedge fund manager headquartered in New York City. The firm was founded by Israel 'Izzy' Englander in 1989 and is a subsidiary of MLM Trust B LLC, itself a subsidiary of MLM Trust B. Millennium Management provides discretionary investment advisory services to private investment funds. | Finance |
Bellevue Research, Inc.
 Bellevue Research, Inc. Investment ManagersFinance Founded in 1998, Bellevue Research, Inc. is a fundamental equity investment research firm located in Boston. The firm is US investment research arm of Bellevue Asset Management AG, a privately-owned asset management group based in Zurich, Switzerland. Their ultimate parent is Bellevue Group AG. Bellevue research provides research to Bellevue Asset Management with coverage of the biotechnology, genetic engineering and pharmaceuticals sectors. | Finance |
North Tide Capital LLC
 North Tide Capital LLC Investment ManagersFinance North Tide Capital LLC is an independent hedge fund management firm headquartered in Boston, Massachusetts. The firm was founded by Conan Laughlin in 2010 as BCL Capital Management. North Tide Capital provides discretionary investment advisory services to institutional investors and other sophisticated investors. | Finance |
| American Express Asset Management Group Inc. | |
Asterion LLC
 Asterion LLC Chemicals: SpecialtyProcess Industries Asterion LLC manufactures chemical finishing products. The company was founded in January and is headquartered in Indianapolis, IN. | Process Industries |
Cormorant Asset Management LP
 Cormorant Asset Management LP Investment ManagersFinance Cormorant Asset Management LLC (Cormorant) is an independent hedge fund manager headquartered in Boston, Massachusetts. The firm was founded by Bi Hua Chen in 2013. Cormorant provides discretionary investment advisory services to hedge funds, private equity funds and separately managed accounts. Investors in the Funds consist of institutional investors and other sophisticated investors. | Finance |
Impresa Management LLC
 Impresa Management LLC Investment ManagersFinance Impresa Management LLC(Impresa Management) is a Private Equity/Venture Capital firm, a subsidiary of Devonshire Investors LLC founded in 1946.The firm is headquartered in Boston. | Finance |
Atia Vision, Inc.
Atia Vision, Inc. Electronic Equipment/InstrumentsElectronic Technology Atia Vision, Inc. provides medical device services. The company was founded in 2012 and is headquartered in Campbell, CA. | Electronic Technology |
| CRMA SPV LP | Finance |
Cormorant Asset Management LLC/Private Equity/
 Cormorant Asset Management LLC/Private Equity/ Investment ManagersFinance Cormorant Asset Management LLC/Private Equity/ (Cormorant Asset Management) is a venture capital subsidiary of Cormorant Asset Management LP founded in 2013 by Bi Hua Chen. The firm is headquartered in Boston, Massachusetts. | Finance |
| Cormorant Private Healthcare Fund I LP | Finance |
| Cormorant Private Healthcare Fund II LP | Finance |
Helix Acquisition Corp.
 Helix Acquisition Corp. Financial ConglomeratesFinance Helix Acquisition Corp. operates as a blank check company. It is a special purpose acquisition company which is incorporated for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded on August 13, 2020 and is headquartered in Boston, MA. | Finance |
| Helix Holdings LLC | |
Blossomhill Therapeutics, Inc.
 Blossomhill Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Blossomhill Therapeutics, Inc. is a small molecule drug discovery and development company that focuses on unmet medical needs in oncology and autoimmune disorders. The company is based in San Diego, CA. Dr. Cui is the lead inventor of multiple oncology medicines and clinical compounds, including crizotinib, lorlatinib, repotrectinib (TPX-0005), TPX-0022, TPX-0046, and TPX-0131. The company was founded by J. Jean Cui, Ph.D., a renowned drug design and development scientist, and Y. Peter Li, Ph.D., M.B.A., a biotech veteran. Jing Rong Cui has been the CEO since incorporation. | Health Technology |
Chroma Medicine, Inc.
Chroma Medicine, Inc. Pharmaceuticals: MajorHealth Technology Chroma Medicine, Inc. is a biotechnology company that pioneers a new class of genomic medicines using epigenetics to deliver precise, programmable single-dose therapeutics while preserving genomic integrity. The company is based in Cambridge, MA and has subsidiaries in Italy. The company's modular platform enables the development of medicines that can address a wide range of complex diseases, whether they require silencing, activation, or targeting multiple genes at once. Chroma Medicine was founded by the world's foremost experts in genomic research and is led by a veteran team of industry leaders and scientists with deep experience in genomic medicine, drug discovery, and development. Catherine Stehman-Breen has been the CEO of the company since 2020. | Health Technology |
Orionis Biosciences BV
Orionis Biosciences BV Pharmaceuticals: MajorHealth Technology Part of Orionis Biosciences, Inc., Orionis Biosciences BV operates as a drug discovery and Belgian development biotechnology company. The private company is based in Ghent, Belgium. The company was founded in 2015. Nikolai Kley has been the CEO of the company since 2015. | Health Technology |
